MiMedx Group, Inc. Increase (Decrease) in Employee Related Liabilities
MiMedx Group, Inc. (MDXG) reported Increase (Decrease) in Employee Related Liabilities of -$17.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-07-29
- MiMedx Group, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was -$1.35M, a 141.10% decline year-over-year.
- MiMedx Group, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$15.71M.
- MiMedx Group, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was $3.42M, a 2.32% decline year-over-year.
- MiMedx Group, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $6.36M, a 54.83% increase year-over-year.
- MiMedx Group, Inc. increase (decrease) in employee related liabilities for fiscal 2025 was $8.99M, a 210.29% increase from fiscal 2024.
- MiMedx Group, Inc. increase (decrease) in employee related liabilities for fiscal 2024 was $2.90M, a 58.34% increase from fiscal 2023.
- MiMedx Group, Inc. increase (decrease) in employee related liabilities for fiscal 2023 was $1.83M.
- MiMedx Group, Inc. increase (decrease) in employee related liabilities for fiscal 2022 was -$1.86M, a 137.12% decline from fiscal 2021.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 3 month as first filed | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 6 month as first filed | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 9 month as first filed | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$17.05M 10-Q · filed 2026-07-29 | -$13.64M derived: sum of 3 quarters · filed 2026-07-29 | -$7.28M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2026-03-31 | -$15.71M 10-Q · filed 2026-04-29 | -$12.29M derived: sum of 2 quarters · filed 2026-04-29 | -$5.93M derived: sum of 3 quarters · filed 2026-04-29 | -$2.65M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-12-31 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $9.78M derived: sum of 2 quarters · filed 2026-02-25 | $13.06M derived: sum of 3 quarters · filed 2026-07-29 | $8.99M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $6.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $9.64M derived: sum of 2 quarters · filed 2026-07-29 | $5.57M 10-Q · filed 2025-10-29 | $9.07M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-06-30 | $3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$791.00K 10-Q · filed 2026-07-29 | $2.71M derived: sum of 3 quarters · filed 2026-07-29 | $6.81M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-03-31 | -$4.07M 10-Q · filed 2026-04-29 | -$577.00K derived: sum of 2 quarters · filed 2026-04-29 | $3.53M derived: sum of 3 quarters · filed 2026-04-29 | $3.26M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2024-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $7.61M derived: sum of 2 quarters · filed 2026-02-25 | $7.34M derived: sum of 3 quarters · filed 2026-02-25 | $2.90M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $4.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $3.84M derived: sum of 2 quarters · filed 2025-10-29 | -$600.00K 10-Q · filed 2025-10-29 | -$703.00K derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-06-30 | -$269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$4.71M 10-Q · filed 2025-07-30 | -$4.81M derived: sum of 3 quarters · filed 2026-02-25 | -$2.96M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-03-31 | -$4.44M 10-Q · filed 2025-04-30 | -$4.54M derived: sum of 2 quarters · filed 2026-02-25 | -$2.69M derived: sum of 3 quarters · filed 2026-02-25 | -$117.00K derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | -$103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.75M derived: sum of 2 quarters · filed 2026-02-25 | $4.32M derived: sum of 3 quarters · filed 2026-02-25 | $1.83M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $4.43M derived: sum of 2 quarters · filed 2024-10-30 | $1.93M 10-Q · filed 2024-10-30 | $1.51M 10-Q · filed 2023-10-30 | -$422.00K derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | $2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $77.00K 10-Q · filed 2024-07-31 | -$345.00K 10-Q · filed 2023-08-01 | -$2.28M derived: sum of 3 quarters · filed 2025-02-26 | $4.53M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | -$2.49M 10-Q · filed 2024-04-30 | -$3.35M 10-Q · filed 2023-05-02 | -$4.85M derived: sum of 2 quarters · filed 2025-02-26 | $1.96M derived: sum of 3 quarters · filed 2025-02-26 | $2.14M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | -$2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $4.46M derived: sum of 2 quarters · filed 2025-02-26 | $4.63M derived: sum of 3 quarters · filed 2025-02-26 | -$1.86M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $6.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $6.99M derived: sum of 2 quarters · filed 2023-10-30 | $495.00K 10-Q · filed 2023-10-30 | $3.42M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | $178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$6.32M 10-Q · filed 2023-08-01 | -$3.39M derived: sum of 3 quarters · filed 2024-02-28 | -$4.10M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | -$6.49M 10-Q · filed 2023-05-02 | -$3.57M derived: sum of 2 quarters · filed 2024-02-28 | -$4.28M derived: sum of 3 quarters · filed 2024-02-28 | $828.00K derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.22M derived: sum of 2 quarters · filed 2024-02-28 | $7.32M derived: sum of 3 quarters · filed 2024-02-28 | $5.01M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | -$705.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $4.40M derived: sum of 2 quarters · filed 2022-11-02 | $2.08M 10-Q · filed 2022-11-02 | ||||
| 2021-06-30 | $5.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $2.79M 10-Q · filed 2022-08-02 | |||||
| 2021-03-31 | -$2.31M 10-Q · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |